Discontinued — last reported Q2 '22
Current Liabilities
Short-Term Borrowings
Medline, Inc. Short-Term Borrowings remained flat by 0.0% to $1.00M in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ3 2019
Last reportedQ2 2022
How to read this metric
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Detailed definition
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Peer comparison
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
Metric ID:
short_term_borrowingsHistorical Data
3 periods
| Q4 '24 | Q4 '25 | Q1 '26 | |
|---|---|---|---|
| Value | $2.00M | $1.00M | $1.00M |
| QoQ Change | — | -50.0% | +0.0% |
| YoY Change | — | -50.0% | — |
Range$1.00M – $2.00M
Avg YoY Growth-50.0%
Median YoY Growth-50.0%
Short-Term Borrowings at Other Companies
Frequently Asked Questions
- What is Medline, Inc. 's short-term borrowings?
- Medline, Inc. (MDLN) reported short-term borrowings of $1.00M in Q1 2026.
- What does short-term borrowings mean?
- Debt that must be repaid within the next twelve months.